http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#Head
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#assertion
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#provenance
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#pubInfo
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#assertion
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
S&T TWOC project version 1
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#version
http://www.w3.org/ns/prov#value
1
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
https://uts.nlm.nih.gov/uts/umls/concept/C1609165
tocilizumab
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
https://uts.nlm.nih.gov/uts/umls/concept/C1609931
siltuximab
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
https://uts.nlm.nih.gov/uts/umls/concept/C3885145
sarilumab
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=TRIPLE_UID:swcqhjom-TRIPLE-ABSTRACT-5
include
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0001617
corticosteroids
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0011777
dexamethasone
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0021760
IL-6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0243077
inhibitors
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1149241
IL-6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1334122
IL-6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1527132
IL-6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1698754
IL-6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C2983957
IL-6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C3539185
corticosteroids
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C3540725
corticosteroids
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C3540726
corticosteroids
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C3540727
corticosteroids
http://www.w3.org/2000/01/rdf-schema#Triple-UID
http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:swcqhjom-TRIPLE-ABSTRACT-5
swcqhjom-TRIPLE-ABSTRACT-5
http://www.w3.org/2000/01/rdf-schema#sentence
http://www.w3.org/2000/01/rdf-schema#label
Currently, there are FDA-approved therapies that attenuate the dysregulated inflammation that occurs in COVID-19 patients, such as dexamethasone or other corticosteroids and IL-6 inhibitors, including sarilumab, tocilizumab, and siltuximab.
http://www.w3.org/2000/01/rdf-schema#triple
http://www.w3.org/2000/01/rdf-schema#label
dexamethasone or other corticosteroids and IL-6 inhibitors including sarilumab , tocilizumab , and siltuximab
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#provenance
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#assertion
http://www.w3.org/ns/prov#generatedAtTime
2021-07-25T21:46:14.949682
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#pubInfo
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#sig
http://purl.org/nanopub/x/hasSignature
T4Tj08g182QZFmw96+spP6sStDsr12QaEMSnYT1hHtRavTWki8ZjVnbeHC6XLB3yzGdHodxLs6Xv4QS7QeklKMOyV9bd+4drm3HuIdDCNpQnlvT+MPOoGkkd5hdAWaQYrFrT0t22NxTQI2/zwZ6BPxu2Ys1UO2O4TecndriGHbM=
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI
http://www.w3.org/ns/prov#generatedAtTime
2021-07-25T21:46:14.949682
http://purl.org/np/RAdGMTmExNJhLpAkplkNI5o4ib-vpBJtyfKDpnO0iA6fI
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-8954-0470